Abstract
Abstract
Background
Patients with cirrhosis undergoing colectomy have a higher risk of postoperative mortality, but contemporary estimates are lacking and data on associated risk and longer term outcomes are limited. This study aimed to quantify the risk of mortality following colectomy by urgency of surgery and stage of cirrhosis.
Data sources.
Linked primary and secondary-care electronic healthcare data from England were used to identify all patients undergoing colectomy from January 2001 to December 2017. These patients were classified by the absence or presence of cirrhosis and severity. Case fatality rates at 90 days and 1 year were calculated, and cox regression was used to estimate the hazard ratio of postoperative mortality controlling for age, gender and co-morbidity.
Results
Of the total, 36,380 patients undergoing colectomy, 248 (0.7%) had liver cirrhosis, and 70% of those had compensated cirrhosis. Following elective colectomy, 90-day case fatality was 4% in those without cirrhosis, 7% in compensated cirrhosis and 10% in decompensated cirrhosis. Following emergency colectomy, 90-day case fatality was higher; it was 16% in those without cirrhosis, 35% in compensated cirrhosis and 41% in decompensated cirrhosis. This corresponded to an adjusted 2.57 fold (95% CI 1.75–3.76) and 3.43 fold (95% CI 2.02–5.83) increased mortality risk in those with compensated and decompensated cirrhosis, respectively. This higher case fatality in patients with cirrhosis persisted at 1 year.
Conclusion
Patients with cirrhosis undergoing emergency colectomy have a higher mortality risk than those undergoing elective colectomy both at 90 days and 1 year. The greatest mortality risk at 90 days was in those with decompensation undergoing emergency surgery.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Byass P (2014) The global burden of liver disease: a challenge for methods and for public health. BMC Med 12(1):159
2. Williams R, Aithal G, Alexander GJ, Allison M, Armstrong I, Aspinall R et al (2020) Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK. Lancet 395(10219):226–239
3. Emerenziani S, Guarino MPL, Trillo Asensio LM, Altomare A, Ribolsi M, Balestrieri P et al (2019) Role of overweight and obesity in gastrointestinal disease. Nutrients 12(1):111
4. Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A (2017) Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc 86(1):93-104.e5
5. Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB et al (2017) Alcohol and gut-derived inflammation. Alcohol Res 38(2):163–171
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献